apolipoprotein studies related to cardiovascular disease

Despite advances in diagnosis, care, and treatment, cardiovascular disease remains the number one killer in the United States and throughout the industrialized world. CAD is particularly common in males, even those less than 50 years old, and in many cases there are no clear risk factors other than a family history of heart disease. Hypercholesterolemia, for example, accounts for less than half of all MIs in the United States. Continuing research on the structure, function, pathophysiology, and heritability of apolipoproteins should lead to improvements in diagnosis, risk assessment, and treatment of cardiovascular and also cerebrovascular diseases.